Syndrome de Hurler (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Syndrome de Hurler" in French language version.

refsWebsite

Global rank French rank

57^th place

4^th place

4^th place

12^th place

2^nd place

3^rd place

1sciencedirect.com

149^th place

80^th place

1biomedcentral.com

2,747^th place

1,253^rd place

2,374^th place

298^th place

biomedcentral.com

ojrd.biomedcentral.com

Parini R, Deodato F, Di Rocco M et al. Open issues in mucopolysaccharidosis type I-Hurler, Orphanet J Rare Dis, 2017;12:112-112

doi.org

dx.doi.org

Doug A. Brooks, « Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I », Expert Opinion on Biological Therapy, vol. 2, n^o 8,‎ décembre 2002, p. 967–976 (ISSN 1471-2598, PMID 12517274, DOI 10.1517/14712598.2.8.967, lire en ligne, consulté le 7 juin 2017)

issn.org

portal.issn.org

Doug A. Brooks, « Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I », Expert Opinion on Biological Therapy, vol. 2, n^o 8,‎ décembre 2002, p. 967–976 (ISSN 1471-2598, PMID 12517274, DOI 10.1517/14712598.2.8.967, lire en ligne, consulté le 7 juin 2017)

nejm.org

Gentner B, Tucci F, Galimberti S et al. Hematopoietic stem- and progenitor-cell gene therapy for Hurler syndrome, N Engl J Med, 2021;385:1929-1940

nih.gov

ncbi.nlm.nih.gov

Doug A. Brooks, « Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I », Expert Opinion on Biological Therapy, vol. 2, n^o 8,‎ décembre 2002, p. 967–976 (ISSN 1471-2598, PMID 12517274, DOI 10.1517/14712598.2.8.967, lire en ligne, consulté le 7 juin 2017)

sciencedirect.com

Langereis EJ, van Vlies N, Church HJ et al. Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy, Mol Genet Metab, 2015;114:129-137.